Literature DB >> 27301780

Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics.

B Prasad1, A Gaedigk2,3, M Vrana4, R Gaedigk2,3, J S Leeder2,3, L Salphati5, X Chu6, G Xiao7, Ceca Hop5, R Evers6, L Gan7, J D Unadkat8.   

Abstract

Protein expression of major hepatic uptake and efflux drug transporters in human pediatric (n = 69) and adult (n = 41) livers was quantified by liquid chromatography / tandem mass spectroscopy (LC-MS/MS). Transporter protein expression of OCT1, OATP1B3, P-gp, and MRP3 was age-dependent. Particularly, significant differences were observed in transporter expression (P < 0.05) between the following age groups: neonates vs. adults (OCT1, OATP1B3, P-gp), neonates or infants vs. adolescents and/or adults (OCT1, OATP1B3, and P-gp), infants vs. children (OATP1B3 and P-gp), and adolescents vs. adults (MRP3). OCT1 showed the largest increase, of almost 5-fold, in protein expression with age. Ontogenic expression of OATP1B1 was confounded by genotype and was revealed only in livers harboring SLCO1B1*1A/*1A. In livers >1 year, tissues harboring SLCO1B1*14/*1A showed 2.5-fold higher (P < 0.05) protein expression than SLCO1B1*15/*1A. Integration of these ontogeny data in physiologically based pharmacokinetic (PBPK) models will be a crucial step in predicting hepatic drug disposition in children.
© 2016 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27301780      PMCID: PMC5017908          DOI: 10.1002/cpt.409

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  43 in total

1.  Thyroidal regulation of different isoforms of NaKATPase in glial cells of developing rat brain.

Authors:  B Banerjee; S Chaudhury
Journal:  Life Sci       Date:  2001-10-05       Impact factor: 5.037

2.  Tissue distribution and ontogeny of organic cation transporters in mice.

Authors:  Yazen Alnouti; Jay S Petrick; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2005-12-28       Impact factor: 3.922

3.  International Transporter Consortium commentary on clinically important transporter polymorphisms.

Authors:  K M Giacomini; P V Balimane; S K Cho; M Eadon; T Edeki; K M Hillgren; S-M Huang; Y Sugiyama; D Weitz; Y Wen; C Q Xia; S W Yee; H Zimdahl; M Niemi
Journal:  Clin Pharmacol Ther       Date:  2013-07       Impact factor: 6.875

4.  Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P-450 2D6 activity.

Authors:  K Allegaert; B J Anderson; R Verbesselt; A Debeer; J de Hoon; H Devlieger; J N Van Den Anker; D Tibboel
Journal:  Br J Anaesth       Date:  2005-06-10       Impact factor: 9.166

Review 5.  Emerging transporters of clinical importance: an update from the International Transporter Consortium.

Authors:  K M Hillgren; D Keppler; A A Zur; K M Giacomini; B Stieger; C E Cass; L Zhang
Journal:  Clin Pharmacol Ther       Date:  2013-04-08       Impact factor: 6.875

6.  The SLCO1B1*5 genetic variant is associated with statin-induced side effects.

Authors:  Deepak Voora; Svati H Shah; Ivan Spasojevic; Shazia Ali; Carol R Reed; Benjamin A Salisbury; Geoffrey S Ginsburg
Journal:  J Am Coll Cardiol       Date:  2009-10-20       Impact factor: 24.094

7.  Induced development of proximal tubular NaKATPase, basolateral cell membranes and fluid reabsorption.

Authors:  A Aperia; L Larsson
Journal:  Acta Physiol Scand       Date:  1984-06

8.  Pharmacokinetics and pharmacodynamics of pravastatin in children with familial hypercholesterolemia.

Authors:  Mia Hedman; Pertti J Neuvonen; Mikko Neuvonen; Marjatta Antikainen
Journal:  Clin Pharmacol Ther       Date:  2003-08       Impact factor: 6.875

9.  Ontogeny of human hepatic and intestinal transporter gene expression during childhood: age matters.

Authors:  Miriam G Mooij; Ute I Schwarz; Barbara A E de Koning; J Steven Leeder; Roger Gaedigk; Janneke N Samsom; Edwin Spaans; Johannes B van Goudoever; Dick Tibboel; Richard B Kim; Saskia N de Wildt
Journal:  Drug Metab Dispos       Date:  2014-05-14       Impact factor: 3.922

10.  Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1.

Authors:  Anne T Nies; Mikko Niemi; Oliver Burk; Stefan Winter; Ulrich M Zanger; Bruno Stieger; Matthias Schwab; Elke Schaeffeler
Journal:  Genome Med       Date:  2013-01-11       Impact factor: 11.117

View more
  57 in total

1.  Toward a Consensus on Applying Quantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics in Translational Pharmacology Research: A White Paper.

Authors:  Bhagwat Prasad; Brahim Achour; Per Artursson; Cornelis E C A Hop; Yurong Lai; Philip C Smith; Jill Barber; Jacek R Wisniewski; Daniel Spellman; Yasuo Uchida; Michael A Zientek; Jashvant D Unadkat; Amin Rostami-Hodjegan
Journal:  Clin Pharmacol Ther       Date:  2019-07-26       Impact factor: 6.875

Review 2.  Aprepitant and fosaprepitant drug interactions: a systematic review.

Authors:  Priya Patel; J Steven Leeder; Micheline Piquette-Miller; L Lee Dupuis
Journal:  Br J Clin Pharmacol       Date:  2017-06-10       Impact factor: 4.335

Review 3.  State-of-the-Art Review on Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development.

Authors:  Venkata Yellepeddi; Joseph Rower; Xiaoxi Liu; Shaun Kumar; Jahidur Rashid; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2019-01       Impact factor: 6.447

4.  Transporter Expression in Noncancerous and Cancerous Liver Tissue from Donors with Hepatocellular Carcinoma and Chronic Hepatitis C Infection Quantified by LC-MS/MS Proteomics.

Authors:  Sarah Billington; Adrian S Ray; Laurent Salphati; Guangqing Xiao; Xiaoyan Chu; W Griffith Humphreys; Mingxiang Liao; Caroline A Lee; Anita Mathias; Cornelis E C A Hop; Christopher Rowbottom; Raymond Evers; Yurong Lai; Edward J Kelly; Bhagwat Prasad; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2017-11-14       Impact factor: 3.922

Review 5.  Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance.

Authors:  Maciej J Zamek-Gliszczynski; Mitchell E Taub; Paresh P Chothe; Xiaoyan Chu; Kathleen M Giacomini; Richard B Kim; Adrian S Ray; Sophie L Stocker; Jashvant D Unadkat; Matthias B Wittwer; Cindy Xia; Sook-Wah Yee; Lei Zhang; Yan Zhang
Journal:  Clin Pharmacol Ther       Date:  2018-08-08       Impact factor: 6.875

6.  Children Are Not Small Adults: Specific Findings in Statin Exposure and Response in a Growing Population.

Authors:  Jonathan B Wagner
Journal:  Clin Pharmacol Ther       Date:  2019-04-10       Impact factor: 6.875

7.  Optimized Renal Transporter Quantification by Using Aquaporin 1 and Aquaporin 2 as Anatomical Markers: Application in Characterizing the Ontogeny of Renal Transporters and Its Correlation with Hepatic Transporters in Paired Human Samples.

Authors:  Cindy Yanfei Li; Chelsea Hosey-Cojocari; Abdul Basit; Jashvant D Unadkat; J Steven Leeder; Bhagwat Prasad
Journal:  AAPS J       Date:  2019-07-11       Impact factor: 4.009

8.  An Optimized Method for Protein Extraction from OCT-Embedded Human Kidney Tissue for Protein Quantification by LC-MS/MS Proteomics.

Authors:  Marc Vrana; Anne Goodling; Maryam Afkarian; Bhagwat Prasad
Journal:  Drug Metab Dispos       Date:  2016-08-01       Impact factor: 3.922

9.  Functional Consequences of Pravastatin Isomerization on OATP1B1-Mediated Transport.

Authors:  Jonathan B Wagner; Melissa Ruggiero; J Steven Leeder; Bruno Hagenbuch
Journal:  Drug Metab Dispos       Date:  2020-09-05       Impact factor: 3.922

10.  Mind the Gaps: Ontogeny of Human Brain P-gp and Its Impact on Drug Toxicity.

Authors:  Jean-Marie Nicolas; Elizabeth C M de Lange
Journal:  AAPS J       Date:  2019-05-28       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.